SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011471
Filing Date
2024-08-08
Accepted
2024-08-08 07:51:00
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlo-20240630x10q.htm   iXBRL 10-Q 1916385
2 EX-10.2 xlo-20240630xex10d2.htm EX-10.2 82757
3 EX-31.1 xlo-20240630xex31d1.htm EX-31.1 13367
4 EX-31.2 xlo-20240630xex31d2.htm EX-31.2 13270
5 EX-32.1 xlo-20240630xex32d1.htm EX-32.1 7879
  Complete submission text file 0001558370-24-011471.txt   6466591

Data Files

Seq Description Document Type Size
6 EX-101.SCH xlo-20240630.xsd EX-101.SCH 42989
7 EX-101.CAL xlo-20240630_cal.xml EX-101.CAL 36593
8 EX-101.DEF xlo-20240630_def.xml EX-101.DEF 209193
9 EX-101.LAB xlo-20240630_lab.xml EX-101.LAB 380893
10 EX-101.PRE xlo-20240630_pre.xml EX-101.PRE 329999
68 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240630x10q_htm.xml XML 749089
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40925 | Film No.: 241186115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)